Extracorporeal membrane oxygenation support in COVID | 合法醫療器材資訊網

由 J Badulak 著作 · 2021 · 被引用 16 次 — The great majority of COVID-19 patients (>90%) requiring ECMO have been supported using venovenous (V-V) ECMO for acute respiratory distress ... Read More

2021年7月1日 — Rationale: The role of and needs for extracorporeal membrane oxygenation (ECMO) at a population level during the coronavirus disease ... Read More

由 MG Fitzsimons 著作 — VV ECMO is an option in COVID-19 for eligible adults with ARDS. Candidates are refractory to conventional ventilator management, with an ... Read More

由 J Badulak 著作 · 2021 · 被引用 15 次 — The great majority of COVID-19 patients (>90%) requiring ECMO have been supported using venovenous (V-V) ECMO for acute respiratory distress syndrome (ARDS). Read More

由 RP Barbaro 著作 · 2020 · 被引用 192 次 — In patients with COVID-19 who received ECMO, both estimated mortality 90 days after ECMO and mortality in those with a final disposition of ... Read More

由 G Lebreton 著作 · 被引用 7 次 — Although COVID-19 can be clinically expressed in several organs, severe acute respiratory distress syndrome (ARDS) is the most common life- ... Read More

FDA released guidance for industry and FDA staff on Enforcement Policy for Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass Devices During the ... Read More

2021年2月1日 — Registry data reaffirmed extracorporeal membrane oxygenation (ECMO) as a reasonable strategy for COVID-19 patients with severe respiratory ... Read More